Why Do I Still Need a Lung Biopsy After My ILD CT Scan?

A high-resolution CT (HRCT) scan is excellent at showing where lung damage is happening, but it doesn’t always reveal exactly what is causing it. When the visual pattern on the scan overlaps with multiple conditions, a lung biopsy allows a pathologist to examine the actual tissue under a microscope. While an HRCT shows the overall pattern of scarring, the tissue provides microscopic cellular clues that can increase your care team’s confidence in the diagnosis and help them choose the safest, most effective treatment plan.

The Limits of the HRCT “Map”

An HRCT scan provides a highly detailed map of your lungs. Sometimes, this map shows a classic, unmistakable pattern—such as a “definite UIP” (Usual Interstitial Pneumonia) pattern. When this happens, a multidisciplinary medical team (including pulmonologists, radiologists, and pathologists) can often confidently diagnose a condition like Idiopathic Pulmonary Fibrosis (IPF) without needing a biopsy ^[1][2].

However, in many cases, the scan results are “indeterminate” or show a “probable” pattern ^[1]. Different types of Interstitial Lung Disease (ILD) can look nearly identical on a scan. For example, the scarring from an autoimmune disease, an environmental exposure, or IPF can all cause similar shadows and lines on imaging ^[1].

What Happens Before a Biopsy?

Because a biopsy is an invasive procedure, it is not an automatic next step. According to international respiratory guidelines, before considering a biopsy, your care team should first:

• Perform a detailed review of your exposures (occupational, hobbies, pets) and medications ^[2].
• Run blood tests to look for autoimmune or connective tissue diseases ^[2].
• Discuss your case in a multidisciplinary ILD meeting ^[1][2].

A biopsy is typically only recommended if the expected information from the tissue will significantly change your treatment plan, and if your lungs and overall health are strong enough to safely undergo the procedure ^[2][3].

What Does a Biopsy Involve?

If your team recommends a biopsy, there are two main procedures they might suggest. The choice depends on your lung function, oxygen needs, and the experience of the medical center ^[4].

What the Microscope Reveals: Cellular Clues

Under a microscope, pathologists search for specific features that distinguish one type of ILD from another. It is important to know that terms like “UIP” or “NSIP” describe patterns of damage on tissue or imaging, not necessarily the final disease name.

• Patchy vs. Uniform Damage (UIP vs. NSIP): UIP typically shows patchy, uneven scarring, where areas of dense damage sit directly next to healthy lung tissue ^[11][12]. NSIP (Nonspecific Interstitial Pneumonia) usually shows a more uniform spread of inflammation and scarring with preserved underlying lung structure ^[13].
• Granulomas: These are distinct clusters of immune cells. Their presence strongly suggests conditions like hypersensitivity pneumonitis (an immune-mediated reaction to inhaled antigens like mold or bird proteins), sarcoidosis, or an infection ^[14]. While they don’t completely rule out IPF, they make it much less likely.
• Lymphoid Follicles: These are organized collections of inflammatory cells. When seen in a biopsy, they can support the idea that an underlying autoimmune or connective tissue disease is involved ^[15][16].
• Fibroblast Foci: These are microscopic zones of active scar formation. Finding them confirms an active fibrotic (scarring) process ^[14][11].

How the Results Change Treatment

Your medical team uses the biopsy results alongside your clinical history and imaging to tailor your therapy. Some conditions, like cellular NSIP or certain autoimmune ILDs, may respond well to immune-suppressing medications ^[17][16]. Conversely, if the biopsy and multidisciplinary review confirm IPF, immune-suppressants could actually be harmful. IPF is generally treated with anti-fibrotic medications that slow down scarring. Getting a clear answer helps your team avoid ineffective treatments and choose the most appropriate path for your specific lungs.

What If I Do Not Have a Biopsy?

Choosing not to have a biopsy is a valid option, especially if the risks are too high. If you decline a biopsy, your care team won’t just do nothing. Instead, they will establish a “working diagnosis” based on the information they already have. They will monitor your symptoms and lung function over time, and they may revisit the diagnosis if your condition changes or new information emerges ^[3].